Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Content:

  • => Which research topics does Medical University of Graz work on? .
  • => Who is involved and which methods are applied? .
  • => Which funding organisations support which research projects? .
  • => In which journals do our researchers publish their findings? .

Facts and Figures: 2.634 researcher profiles (with 1581 ORCID-IDs), 8.621 research projects, 153.522 publications, posters and lectures, 63.635 fulltext links (free full text accessible: 27.836 (Open Access) )

Number of citations in Web of Science: 1.931.588 with 3.776 citation classics (>=100 citations) Sum Altmetrics Score: 294.997

Recent by funding organisations approved projects:

Modernizing planetary protection toolkits: enabling the new era for space exploration
Project Leader: Mahnert Alexander
Duration: 01.10.2025 - 30.09.2028
Funded by: European Space Agency - ESA

Elemental and Structural Composition underlying Brain MRI
Project Leader: Langkammer Christian
Duration: 01.10.2025 - 30.09.2030
Funded by: Europäische Kommission

> More new projects

Most recent publications in "top-journals" (top 20 % impact ranking):


23.06.2025:

Petersen, M; Coenen, M; DeCarli, C; De Luca, A; van der Lelij, E; Barkhof, F; Benke, T; Chen, CPLH; Dal-Bianco, P; Dewenter, A; Duering, M; Enzinger, C; Ewers, M; Exalto, LG; Fletcher, EM; Franzmeier, N; Hilal, S; Hofer, E; Koek, HL; Maier, AB; Maillard, PM; McCreary, CR; Papma, JM; Pijnenburg, YAL; Schmidt, R; Smith, EE; Steketee, RME; van den Berg, E; van der Flier, WM; Venkatraghavan, V; Venketasubramanian, N; Vernooij, MW; Wolters, FJ; Xu, X; Horn, A; Patil, KR; Eickhoff, SB; Thomalla, G; Biesbroek, JM; Biessels, GJ; Cheng, BS Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment
BRAIN. 2024; 147(12): 4265-4279. Doi: 10.1093/brain/awae315
Web of Science FullText FullText_MUG

 

23.06.2025:

Gutjahr, JC; Hub, E; Anderson, CA; Samus, M; Artinger, K; Gomez, EA; Ratswohl, C; Wickli, N; Raum, M; Dufton, N; Dalli, J; Burden, JJ; Duchene, J; Rot, A Intracellular and nuclear CXCR4 signaling promotes terminal erythroblast differentiation and enucleation
SCI SIGNAL. 2025; 18(891): eadt2678 Doi: 10.1126/scisignal.adt2678
Web of Science PubMed FullText FullText_MUG

 

23.06.2025:

Schneider, JS; Ben Khaled, N; Ye, LT; Wimmer, R; Hammann, L; Weich, A; Suppan, C; Mahajan, UM; Jung, AD; Kumbrink, J; Denk, G; Rau, M; Kunzmann, V; Kuss, S; Neuman, J; Mayerle, J; Geier, A; Hermanns, HM; De Toni, EN; Reiter, FP Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance
CELL ONCOL. 2025; Doi: 10.1007/s13402-025-01080-7
Web of Science PubMed FullText FullText_MUG

 

23.06.2025:

Jahn, N; Metnitz, P; Sucher, R; Karitnig, R; Laudi, S; Hau, HM Challenges of (postoperative) cancer patients in the ICU
BEST PRAC RES-CL ANA. 2025; 39(1): 57-70. Doi: 10.1016/j.bpa.2025.03.005
Web of Science FullText FullText_MUG

 

23.06.2025:

Berger, N; Rieder, A; Brugger, K; Amtmann, B; Kollmann, M; Oreskovic, I; Trajanoski, S; Hiden, U; Fluhr, H Novel link between plasma bilirubin and anti-inflammatory miRNA profiles in follicular fluid of IVF patients
AM J PHYSIOL-ENDOC M. 2025; 328(6): E1001-E1012. Doi: 10.1152/ajpendo.00479.2024
Web of Science PubMed FullText FullText_MUG

 

23.06.2025:

Álvarez-Bustos, A; Coelho-Junior, HJ; Calvani, R; Rodriguez-Mañas, L; Tosato, M; Cesari, M; Cherubini, A; Cruz-Jentoft, AJ; Jónsson, PV; Lattanzio, F; Maggio, M; Roller-Wirnsberger, R; Rýznarová, I; Schols, AMWJ; Sieber, CC; Sinclair, AJ; Skalska, A; Strandberg, T; Tchalla, A; Topinková, E; Vellas, B; von, Haehling, S; Landi, F; Marzetti, E, , SPRINTT, consortium Adherence to Physical Activity and Incident Mobility Disability in Older Adults With Mobility Limitations.
J Cachexia Sarcopenia Muscle. 2025; 16(3):e13870 Doi: 10.1002/jcsm.13870 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

23.06.2025:

Aksentijevic, D; Sedej, S; Fauconnier, J; Paillard, M; Abdellatif, M; Streckfuss-Bömeke, K; Ventura-Clapier, R; van, der, Velden, J; de, Boer, RA; Bertero, E; Dudek, J; Sequeira, V; Maack, C Mechano-energetic uncoupling in heart failure.
Nat Rev Cardiol. 2025; Doi: 10.1038/s41569-025-01167-6
PubMed FullText FullText_MUG

 

23.06.2025:

Maertens, JA; Thompson, GR; Spec, A; Donovan, FM; Hammond, SP; Bruns, AHW; Rahav, G; Shoham, S; Johnson, R; Rijnders, B; Schaenman, J; Hoenigl, M; Morrissey, CO; Mehta, SR; Heath, CH; Koehler, P; Paterson, DL; Slavin, MA; Fortún, J; Nguyen, MH; Patterson, TF; Uspenskaya, O; Van, de, Veerdonk, FL; Verweij, PE; Aoun, M; Georgala, A; Alexander, BD; Chayakulkeeree, M; Mehra, V; Miceli, MH; Sikka, MK; Solé, A; Walsh, TJ; Aguado, JM; Holland, SM; Moussa, M; Rautemaa-Richardson, R; Bazaz, R; Schwartz, S; Walsh, SR; Plate, M; Yehudai-Ofir, D; Brüggemann, RJ; Cornely, OA; Ostrosky-Zeichner, L; Vazquez, JA; White, PL; Cornelissen, K; Ross, GG; Fitton, L; Dane, A; Zinzi, D; Rex, JH; Chen, SC Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
Lancet Infect Dis. 2025; Doi: 10.1016/S1473-3099(25)00224-5
PubMed FullText FullText_MUG

 

23.06.2025:

Benezeder, T; Bordag, N; Woltsche, J; Teufelberger, A; Perchthaler, I; Weger, W; Salmhofer, W; Gruber-Wackernagel, A; Painsi, C; Zhan, Q; El-Heliebi, A; Babina, M; Clark, R; Wolf, P Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment.
J Dermatol Sci. 2025; Doi: 10.1016/j.jdermsci.2025.05.006
PubMed FullText FullText_MUG

 

23.06.2025:

Balcar, L; Fromme, M; Kappe, N; Schaefer, B; Fraňková, S; van, Melkebeke, L; Stolk, J; Jachs, M; Semmler, G; Hofer, BS; Tergast, TL; Rieland, H; Karl, AS; Sperl, J; Wagner, M; Pons, M; Hofer, H; Peck-Radosavljevic, M; Trauner, M; Reiberger, T; Maasoumy, B; Zoller, H; van, Hoek, B; Verbeek, J; Strnad, P; Mandorfer, M Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis.
JHEP Rep. 2025; 7(6):101398 Doi: 10.1016/j.jhepr.2025.101398 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

23.06.2025:

Altendorfer, B; Poupardin, R; Lefèvre-Arbogast, S; Manach, C; Low, DY; Urpi-Sarda, M; Andres-Lacueva, C; González-Domínguez, R; Felder, TK; Tevini, J; Zattoni, M; Koller, A; Schmidt, R; Lucassen, PJ; Ruigrok, SR; de, Lucia, C; Du, Preez, A; Helmer, C; Neuffer, J; Proust-Lima, C; Korosi, A; Samieri, C; Thuret, S; Aigner, L Blood serum from individuals with Alzheimer's disease alters microglial phagocytosis in vitro.
Neural Regen Res. 2025; Doi: 10.4103/NRR.NRR-D-24-01287
PubMed FullText FullText_MUG

 

22.06.2025:

Rasouli, N; Guder, Arslan, E; Catarig, AM; Houlind, K; Ludvik, B; Nordanstig, J; Sourij, H; Thomas, S; Verma, S; Bonaca, MP Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial.
Diabetes Care. 2025; Doi: 10.2337/dc25-1082
PubMed FullText FullText_MUG

 

20.06.2025:

Rossing, P; Birkenfeld, AL; Fioretto, P; McGill, JB; Anker, SD; Pitt, B; Rohwedder, K; Scalise, A; Scott, C; Filippatos, G, , FIDELIO-DKD, and, FIGARO-DKD, Investigators Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc Analysis.
Clin J Am Soc Nephrol. 2025; Doi: 10.2215/CJN.0000000700
PubMed FullText FullText_MUG

 

16.06.2025:

Weinberger, V; Darnhofer, B; Thapa, HB; Mertelj, P; Stentz, R; Jones, E; Grabmann, G; Mohammadzadeh, R; Shinde, T; Karner, C; Ober, J; Juodeikis, R; Pernitsch, D; Hingerl, K; Zurabishvili, T; Kumpitsch, C; Kuehnast, T; Rinner, B; Strohmaier, H; Kolb, D; Gotts, K; Weichhart, T; Köcher, T; Köfeler, H; Carding, SR; Schild, S; Moissl-Eichinger, C Proteomic and metabolomic profiling of extracellular vesicles produced by human gut archaea
NAT COMMUN. 2025; 16(1): 5094 Doi: 10.1038/s41467-025-60271-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

16.06.2025:

Klingenberg, R; Leiherer, A; Dobrev, D; Kaski, JC; Levkau, B; März, W; Sossalla, S; von Eckardstein, A; Drexel, H Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets
CARDIOVASC RES. 2025; Doi: 10.1093/cvr/cvaf093
Web of Science PubMed FullText FullText_MUG

 

16.06.2025:

Cerrato, G; Sauvat, A; Abdellatif, M; Kroemer, G Potent immune-dependent anticancer effects of the non-cardiotoxic anthracycline aclarubicin
ONCOIMMUNOLOGY. 2025; 14(1): 2515176 Doi: 10.1080/2162402X.2025.2515176 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

16.06.2025:

Mangge, H Lipid Metabolism and Relevance to Chronic Disease
NUTRIENTS. 2025; 17(11): 1936 Doi: 10.3390/nu17111936 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

16.06.2025:

Byrski, A; Szawiraacz, K; Lackner, JM; Lumenta, DB; Surmiak, M; Dyner, M; Kasperkiewicz, K; Kurtyka, P; Kopernik, M; Major, R Restoration of biomechanical and biological conditions for the finger implant to properly assess the suitability of the implant
ARCH CIV MECH ENG. 2025; 25(4): 180 Doi: 10.1007/s43452-025-01217-3
Web of Science FullText FullText_MUG

 

> Further new publications in top journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni GrazImprint